Corresponding Author: Linda Brubaker, MD, Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, 9500 Gilman Dr, MC 0971, La Jolla, CA 92075 (librubaker@ucsd.edu).
Published Online: January 29, 2020. doi:10.1001/jama.2019.21377
Conflict of Interest Disclosures: Dr Aslam reported receiving personal fees as a consultant from Merck. Dr Brubaker reported receiving grants from the National Institutes of Health and editorial stipends from Female Pelvic Medicine & Reconstructive Surgery and UpToDate. No other disclosures were reported.
1.Wagenlehner
F, Wullt
B, Ballarini
S, Zingg
D, Naber
KG. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT).
Expert Rev Pharmacoecon Outcomes Res. 2018;18(1):107-117.
PubMedGoogle ScholarCrossref 2.Nicolle
LE, Gupta
K, Bradley
SF,
et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America.
Clin Infect Dis. 2019;68(10):1611-1615. doi:
10.1093/cid/ciz021PubMedGoogle ScholarCrossref 3.Brubaker
L, Carberry
C, Nardos
R, Carter-Brooks
C, Lowder
JL. American Urogynecologic Society best-practice statement: recurrent urinary tract infection in adult women.
Female Pelvic Med Reconstr Surg. 2018;24(5):321-335.
PubMedGoogle ScholarCrossref